Synhale Therapeutics Inc. (Synhale), a virtual, clinical-stage biotech company committed to transforming Pulmonary Hypertension (PH), announced the acquisition of Telaglenastat (CB-839), the ...

Babson Diagnostics, a science-first healthcare technology company revolutionizing diagnostic blood testing, today announced the appointment of Web Golinkin as President and Chief Commercial Officer.

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Stacey Davis appointed as Chief Business Officer and Chief Financial Officer ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the ...

The American Association for Cancer Research’s annual conference continued Tuesday with Marengo Therapeutics making progress ...

From enabling functional cures for genetic diseases to revolutionizing agriculture and biotechnology, CRISPR is poised to reshape global industries. The next decade will witness deeper integration of ...

Enhancing wheat plants’ sugar signalling ability could deliver increased yields of up to 12%, according to researchers from ...

A key highlight was the signing of a licensing agreement between Taiwan -based DuoGenic StemCells and Japan's A&I Corporation ...

Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...